-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) Short Interest Update
Deep Medicine Acquisition Corp. (NASDAQ:DMAQ) Short Interest Update
Deep Medicine Acquisition Corp. (NASDAQ:DMAQ – Get Rating) saw a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,900 shares, an increase of 210.5% from the October 15th total of 1,900 shares. Based on an average trading volume of 22,800 shares, the short-interest ratio is currently 0.3 days. Currently, 0.1% of the shares of the stock are sold short.
Deep Medicine Acquisition Trading Up 0.1 %
DMAQ stock opened at $10.10 on Friday. Deep Medicine Acquisition has a 12 month low of $9.70 and a 12 month high of $10.99. The firm has a 50-day moving average of $10.07 and a two-hundred day moving average of $10.02.
Get Deep Medicine Acquisition alerts:Institutional Trading of Deep Medicine Acquisition
Several hedge funds have recently made changes to their positions in the company. Saba Capital Management L.P. grew its stake in shares of Deep Medicine Acquisition by 11.2% in the 1st quarter. Saba Capital Management L.P. now owns 1,009,157 shares of the company's stock valued at $10,041,000 after buying an additional 102,016 shares during the period. Wolverine Asset Management LLC grew its stake in shares of Deep Medicine Acquisition by 3.3% in the 2nd quarter. Wolverine Asset Management LLC now owns 354,543 shares of the company's stock valued at $3,534,000 after buying an additional 11,300 shares during the period. Hsbc Holdings PLC purchased a new stake in shares of Deep Medicine Acquisition in the 1st quarter valued at approximately $2,976,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of Deep Medicine Acquisition in the 1st quarter valued at approximately $498,000. Finally, Millennium Management LLC boosted its position in shares of Deep Medicine Acquisition by 29.5% during the 2nd quarter. Millennium Management LLC now owns 42,719 shares of the company's stock worth $426,000 after purchasing an additional 9,719 shares during the period. Hedge funds and other institutional investors own 89.62% of the company's stock.
About Deep Medicine Acquisition
(Get Rating)Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry.
Further Reading
- Get a free copy of the StockNews.com research report on Deep Medicine Acquisition (DMAQ)
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Coupang Stock And Why You Should Care
- This Is No Time To Buy D.R. Horton Stock
- Tightly Held Wendy's Is Undervalued
Receive News & Ratings for Deep Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deep Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Deep Medicine Acquisition Corp. (NASDAQ:DMAQ – Get Rating) saw a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 5,900 shares, an increase of 210.5% from the October 15th total of 1,900 shares. Based on an average trading volume of 22,800 shares, the short-interest ratio is currently 0.3 days. Currently, 0.1% of the shares of the stock are sold short.
深度医药收购公司(纳斯达克代码:dmaq-Get Rating)在10月份见证了空头股数的大幅增长。截至10月31日,空头股数共有5,900股,比10月15日的1,900股增加了210.5%。以平均成交量22,800股计算,目前短息比为0.3天。目前,该股0.1%的股份被卖空。
Deep Medicine Acquisition Trading Up 0.1 %
深度医药收购交易上涨0.1%
DMAQ stock opened at $10.10 on Friday. Deep Medicine Acquisition has a 12 month low of $9.70 and a 12 month high of $10.99. The firm has a 50-day moving average of $10.07 and a two-hundred day moving average of $10.02.
DMAQ股票周五开盘报10.10美元。Deep Medicine的收购价为9.70美元,为12个月低点,12个月高位为10.99美元。该公司的50日移动均线切入位在10.07美元,200日移动均线切入位在10.02美元。
Institutional Trading of Deep Medicine Acquisition
深度医药收购的制度性交易
Several hedge funds have recently made changes to their positions in the company. Saba Capital Management L.P. grew its stake in shares of Deep Medicine Acquisition by 11.2% in the 1st quarter. Saba Capital Management L.P. now owns 1,009,157 shares of the company's stock valued at $10,041,000 after buying an additional 102,016 shares during the period. Wolverine Asset Management LLC grew its stake in shares of Deep Medicine Acquisition by 3.3% in the 2nd quarter. Wolverine Asset Management LLC now owns 354,543 shares of the company's stock valued at $3,534,000 after buying an additional 11,300 shares during the period. Hsbc Holdings PLC purchased a new stake in shares of Deep Medicine Acquisition in the 1st quarter valued at approximately $2,976,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in shares of Deep Medicine Acquisition in the 1st quarter valued at approximately $498,000. Finally, Millennium Management LLC boosted its position in shares of Deep Medicine Acquisition by 29.5% during the 2nd quarter. Millennium Management LLC now owns 42,719 shares of the company's stock worth $426,000 after purchasing an additional 9,719 shares during the period. Hedge funds and other institutional investors own 89.62% of the company's stock.
几家对冲基金最近对他们在该公司的头寸进行了调整。第一季度,萨巴资本管理公司(Saba Capital Management L.P.)在深度医药收购中的持股增加了11.2%。Saba Capital Management L.P.在此期间又购买了102,016股,现在拥有1,009,157股该公司股票,价值10,041,000美元。金刚狼资产管理有限责任公司在第二季度增持了深度医药收购股份3.3%。金刚狼资产管理有限责任公司现在拥有345,543股该公司的股票,价值3,534,000美元,在此期间又购买了11,300股。汇丰控股在第一季度购买了深医收购的新股,价值约297.6万美元。宾夕法尼亚州联邦公立学校Empls Retrmt Systems在第一季度购买了Deep Medicine收购公司的新股份,价值约49.8万美元。最后,千禧管理有限责任公司在第二季度将其在深度医药收购中的股份头寸增加了29.5%。Millennium Management LLC现在拥有42,719股该公司的股票,价值426,000美元,在此期间又购买了9,719股。对冲基金和其他机构投资者持有该公司89.62%的股票。
About Deep Medicine Acquisition
关于深度医学的收购
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry.
深度医药收购公司没有重大业务。公司拟与一家或多家企业进行合并、资本换股、资产收购、股票购买、重组或类似的业务合并。它专注于识别医疗保健行业的企业。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Deep Medicine Acquisition (DMAQ)
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Coupang Stock And Why You Should Care
- This Is No Time To Buy D.R. Horton Stock
- Tightly Held Wendy's Is Undervalued
- 免费获取StockNews.com关于深度医学收购的研究报告(DMAQ)
- Hanesbrand可能发出零售类股本周表现不佳的信号
- 愿景氢,现在的愿景能源,将希望寄托在股票拆分上
- 优惠券股票和你为什么应该关心
- 现在不是购买D.R.霍顿股票的时候
- 严密持有的温迪百货公司被低估了
Receive News & Ratings for Deep Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deep Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接受深度医疗收购日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯,接收最新新闻和分析师对深度医药收购和相关公司评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧